Nasdaq:US$15.10 (-0.24) | HKEX:HK$23.75 (-0.45) | AIM:£2.19 (-0.02)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate